Congrats to Sara for the acceptance of two papers, both using biomaterial models to examine how the glioblastoma tumor microenvironment may alter how GBM cells respond to tyrosine kinase inhibitors. ‘Extracellular hyaluronic acid influences the efficacy of EGFR tyrosine kinase inhibitors in a biomaterial model of glioblastoma’ is out in Advanced Healthcare Materials, while ‘Spatially-graded hydrogels for preclinical testing of glioblastoma anticancer therapeutics’ has been accepted in MRS Communications. Both involve an exciting collaboration with Mayo Clinic and our use of patient-derived biospecimens (not cell lines)!
Engineering cellular microenvironments and microstructures